[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334955-105":59,"doc-detail-334955-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","genetically-predicted-91-circulating-inflammatory-proteins-in-relation-to-risk-of-urological-malignancies-a-mendelian-randomization-study","Genetically predicted 91 circulating inflammatory proteins in relation to risk of urological malignancies - a Mendelian randomization study","","Urological malignancies, including kidney, bladder, and prostate cancers, are major health concerns worldwide, and inflammation is implicated in their development. This study evaluates whether specific circulating inflammatory plasma proteins causally influence cancer risk. A two-sample Mendelian randomization framework uses GWAS summary statistics and genetic instruments for protein–cancer associations, applying multiple MR methods and robustness checks to estimate effects.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/genetically-predicted-91-circulating-inflammatory-proteins-in-relation-to-risk-of-urological-malignancies-a-mendelian-randomization-study/334955/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/genetically-predicted-91-circulating-inflammatory-proteins-in-relation-to-risk-of-urological-malignancies-a-mendelian-randomization-study/334955.png","ImageObject",300,407,{"name":92,"@type":93},"Maeve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the study’s main objective regarding inflammatory proteins and urological cancers?","Question",{"text":113,"@type":114},"To test whether specific genetically predicted circulating inflammatory plasma proteins have a causal relationship with the risk of kidney, bladder, and prostate cancers.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was causality assessed in this study?",{"text":118,"@type":114},"Using a two-sample Mendelian randomization approach based on GWAS summary statistics and genetic variants associated with circulating inflammatory proteins.",{"name":120,"@type":111,"acceptedAnswer":121},"What were the key findings for kidney and bladder cancer after multiple-testing adjustment?",{"text":122,"@type":114},"Several proteins showed associations with lower risk of kidney and bladder cancer in the initial analysis, but these associations were not statistically significant after adjusting for multiple testing.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334955,1790467230,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 12  \nResearch Paper  \nGenetically predicted 91 circulating inflammatory proteins in relation to risk of urological malignancies: a Mendelian randomization study  \nJianxiong Xu1,*, Ru Chen1,*, Yucheng Yang1, Sufang Xu2, Lijing Yao1  \n1 Department of Radiotherapy, The First Hospital of Putian City, Putian, Fujian 351100, China 2 Department of Proctology of Traditional Chinese Medicine, The First Hospital of Putian City, Putian, Fujian 351100, China  \n*Co-first authors  \nCorrespondence to: Lijing Yao; email: [flkyaolijing@sina.com](flkyaolijing@sina.com), [https://orcid.org/0009-0009-6593-9768](https://orcid.org/0009-0009-6593-9768)[ ](https://orcid.org/0009-0009-6593-9768)[Keywords:](Keywords: urological malignancies)[ urological malignancies](Keywords: urological malignancies), kidney cancer, bladder cancer, prostate cancer, inflammatory proteins, Mendelian randomization  \nReceived: December 20, 2023 Accepted: May 6, 2024 Published: June 13, 2024  \nCopyright: © 2024 Xu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nBackground: Urological malignancies, including kidney, bladder, and prostate cancer, are major health concerns worldwide. Inflammation has been implicated in the pathogenesis of these cancers, and circulating inflammatory proteins may play a role in their development. However, the causal relationship between specific plasma proteins and urological malignancies remains unclear.  \nMethods: We performed a two-sample Mendelian randomization (MR) analysis using summary statistics from genome-wide association studies (GWAS). Instrumental variables representing genetic variants associated with circulating inflammatory proteins were used to infer causality on the risk of kidney, bladder, and prostate cancer. Four MR methods were utilized to provide robust effect estimates.  \nResults: Our analysis identified several plasma proteins associated with a lower risk of kidney and bladder cancer, including Eukaryotic translation initiation factor 4E-binding protein 1, Caspase 8, Natural killer cell receptor 2B4, and Tumor necrosis factor ligand superfamily member 12. However, after adjusting for multiple testing, these associations did not remain statistically significant. For prostate cancer, CUB domain-containing protein 1 and Interleukin-10 receptor subunit beta were found to be protective, while Glial cell line-derived neurotrophic factor and SIR2-like protein 2 were identified as risk factors. After FDR adjustment, none of the inflammatory proteins were found to be significantly associated with a lower risk of prostate cancer. Conclusion: Our findings suggest that certain plasma proteins may be involved in the development of urological malignancies. Mendelian randomization provides a useful framework for investigating causal relationships between inflammatory proteins and urological cancers, offering potential insights into their underlying biology and therapeutic targets.  \nINTRODUCTION  \nCancer is a leading cause of mortality worldwide, and urological tumors, including kidney, prostate, and bladder cancers, contribute significantly to this burden  \n[1, 2] . Traditionally, the development and progression of cancer have been attributed to genetic mutations and environmental factors. However, emerging evidence now suggests that chronic inflammation also plays a crucial role in the pathogenesis of various cancers.  \n10366  \nWhile chronic inflammation is directly associated with cancer development in only about 20% of cases, it is believed to indirectly contribute to tumorigenesis in a more substantial percentage of patients [1] . In the context of urological cancers, chronic inflammation induced by bacterial or viral infections is not a primary cause. ","cbCaie9CfzipWNJG","https://ap.wps.com/l/cbCaie9CfzipWNJG","pdf",2520203,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Role of chronic inflammation in urological cancers\n## Systemic inflammatory response markers in prognosis\n## Treatment context and research motivation","[{\"question\":\"What is the study’s main objective regarding inflammatory proteins and urological cancers?\",\"answer\":\"To test whether specific genetically predicted circulating inflammatory plasma proteins have a causal relationship with the risk of kidney, bladder, and prostate cancers.\"},{\"question\":\"How was causality assessed in this study?\",\"answer\":\"Using a two-sample Mendelian randomization approach based on GWAS summary statistics and genetic variants associated with circulating inflammatory proteins.\"},{\"question\":\"What were the key findings for kidney and bladder cancer after multiple-testing adjustment?\",\"answer\":\"Several proteins showed associations with lower risk of kidney and bladder cancer in the initial analysis, but these associations were not statistically significant after adjusting for multiple testing.\"}]","Genetically predicted 91 circulating inflammatory proteins in relation to risk of urological malignancies - a Mendelian randomization study | PDF",1790009008,35]